Racial disparities among patients with lung cancer who were recommended operative therapy
- PMID: 19153319
- PMCID: PMC2688646
- DOI: 10.1001/archsurg.2008.519
Racial disparities among patients with lung cancer who were recommended operative therapy
Abstract
Hypothesis: Health care system and provider biases and differences in patient characteristics are thought to be prevailing factors underlying racial disparities. The influence of these factors on the receipt of care would likely be mitigated among patients who are recommended optimal therapy. We hypothesized that there would be no significant evidence of racial disparities among patients with early-stage lung cancer who are recommended surgical therapy.
Design, setting, and patients: Retrospective cohort study of patients in the Surveillance, Epidemiology, and End Results-Medicare database who were diagnosed with stage I or II lung cancer between January 1, 1992, and December 31, 2002 (follow-up through December 31, 2005).
Main outcome measures: Receipt of lung resection and overall survival.
Results: Among 17,739 patients who were recommended surgical therapy (mean [SD] age, 75 [5] years; 89% white, 6% black), black patients less frequently underwent resection compared with white patients (69% vs 83%, respectively; P < .001). After adjustment, black race was associated with lower odds of receiving surgical therapy (odds ratio = 0.43; 99% confidence interval, 0.36-0.52). Unadjusted 5-year survival rates were lower for black patients compared with white patients (36% vs 42%, respectively; P < .001). After adjustment, there was no significant association between race and death (hazard ratio = 1.03; 99% confidence interval, 0.92-1.14) despite a 14% difference in receipt of optimal therapy.
Conclusions: Even among patients who were recommended surgical therapy, black patients underwent lung resection less often than white patients. Unexpectedly, racial differences in the receipt of optimal therapy did not appear to affect outcomes. These findings suggest that distrust, beliefs and perceptions about lung cancer and its treatment, and limited access to care (despite insurance) might have a more dominant role in perpetuating racial disparities than previously recognized.
Comment in
-
Racial disparities in lung cancer care: the unresolved problem.Arch Surg. 2009 Feb;144(2):193. doi: 10.1001/archsurg.2008.548. Arch Surg. 2009. PMID: 19221335 No abstract available.
References
-
- Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin. 2007 Jan-Feb;57(1):43–66. - PubMed
-
- National Comprehensive Cancer Network Clinical practice guidelines in oncology—v.2.2008: non-small cell lung cancer. [Accessed January, 2008]. http://www.nccn.org/professionals/physician_gls/PDF/nscl.pdf. - PubMed
-
- Scott WJ, Howington J, Movsas B. Treatment of stage II non-small cell lung cancer. Chest. 2003 Jan;123(1 Suppl):188S–201S. - PubMed
-
- Smythe WR. Treatment of stage I non-small cell lung carcinoma. Chest. 2003 Jan;123(1 Suppl):181S–187S. - PubMed
-
- Bach PB, Cramer LD, Warren JL, Begg CB. Racial differences in the treatment of early-stage lung cancer. N Engl J Med. 1999 Oct 14;341(16):1198–1205. - PubMed